These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9566770)
1. LEA-1/ICAM-1 interaction is essentially involved in the pathogenesis of delayed-type hypersensitivity-induced liver injury to picryl chloride. Xu Q; Jiang J; Cao J; Wu F; Fujii H; Saiki I Life Sci; 1998; 62(15):1281-92. PubMed ID: 9566770 [TBL] [Abstract][Full Text] [Related]
2. Role of Th1 and Th2 cytokines in regulating the liver injury induced by delayed-type hypersensitivity to picryl chloride. Xu Q; Cao J; Wu F; Hayakawa Y; Saiki I; Koda A Liver; 1999 Dec; 19(6):473-80. PubMed ID: 10661680 [TBL] [Abstract][Full Text] [Related]
3. Liver-infiltrating T lymphocytes cause hepatocyte damage by releasing humoral factors via LFA-1/ICAM-1 interaction in immunological liver injury. Xu Q; Cao JS; Zhang XM Inflamm Res; 2002 Jan; 51(1):44-50. PubMed ID: 11845998 [TBL] [Abstract][Full Text] [Related]
4. Role of CD4+ and CD8+ T cells in regulating the chronic development of liver injury induced by delayed-type hypersensitivity to picryl chloride. Xu Q; Wu F; Jiang J; Lu J; Chen X; Zhang B Int Arch Allergy Immunol; 1998 Jun; 116(2):154-61. PubMed ID: 9652309 [TBL] [Abstract][Full Text] [Related]
5. Role of anti-LFA-1 and anti-ICAM-1 combined MAb treatment in the rejection of tumors induced by Moloney murine sarcoma virus (M-MSV). Rosato A; Mandruzzato S; Bronte V; Zambon A; Macino B; Calderazzo F; Zanovello P; Collavo D Int J Cancer; 1995 May; 61(3):355-62. PubMed ID: 7729948 [TBL] [Abstract][Full Text] [Related]
6. Protective involvement of nitric oxide in the liver injury induced by delayed-type hypersensitivity to picryl chloride. Cao J; Xu Q; Koda A Inflamm Res; 2000 Nov; 49(11):578-83. PubMed ID: 11131297 [TBL] [Abstract][Full Text] [Related]
7. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival. Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody against lymphocyte function-associated antigen 1 inhibits the formation of primary biliary cirrhosis-like lesions induced by murine graft-versus-host reaction. Kimura T; Suzuki K; Inada S; Hayashi A; Isobe M; Matsuzaki Y; Tanaka N; Osuga T; Fujiwara M Hepatology; 1996 Oct; 24(4):888-94. PubMed ID: 8855193 [TBL] [Abstract][Full Text] [Related]
9. Induction of T cell tolerance by pretreatment with anti-ICAM-1 and anti-lymphocyte function-associated antigen-1 antibodies prevents antigen-induced eosinophil recruitment into the mouse airways. Nakao A; Nakajima H; Tomioka H; Nishimura T; Iwamoto I J Immunol; 1994 Dec; 153(12):5819-25. PubMed ID: 7989777 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of mononuclear cell recruitment in aortic intima by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in hypercholesterolemic rats: implications of the ICAM-1 and LFA-1 pathway in atherogenesis. Nie Q; Fan J; Haraoka S; Shimokama T; Watanabe T Lab Invest; 1997 Nov; 77(5):469-82. PubMed ID: 9389790 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. Yasukawa H; Imaizumi T; Matsuoka H; Nakashima A; Morimatsu M Circulation; 1997 Mar; 95(6):1515-22. PubMed ID: 9118520 [TBL] [Abstract][Full Text] [Related]
12. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Ma J; Wang JH; Guo YJ; Sy MS; Bigby M Cell Immunol; 1994 Oct; 158(2):389-99. PubMed ID: 7923390 [TBL] [Abstract][Full Text] [Related]
13. Effects of anti-intercellular adhesion molecule-1 and anti-lymphocyte-function-associated antigen-1 monoclonal antibodies on the metastasis of murine tumors. Sun R; Hojo H; Kato K; Hashimoto Y Invasion Metastasis; 1996; 16(1):39-48. PubMed ID: 8830764 [TBL] [Abstract][Full Text] [Related]
14. Liver injury model in mice induced by a cellular immunologic mechanism--delayed-type hypersensitivity-induced liver injury to picryl chloride and phenotype of effector cell. Xu Q; Wang R; Jiang J; Wu F; Lu J; Tan PK; Xu L Cell Immunol; 1996 Jan; 167(1):38-43. PubMed ID: 8548843 [TBL] [Abstract][Full Text] [Related]
15. 2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1. Carreño R; Brown WS; Li D; Hernandez JA; Wang Y; Kim TK; Craft JW; Komanduri KV; Radvanyi LG; Hwu P; Molldrem JJ; Legge GB; McIntyre BW; Ma Q J Biol Chem; 2010 Oct; 285(43):32860-32868. PubMed ID: 20724473 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of monoclonal antibodies against LFA-1 and ICAM-1 on myocardial reperfusion injury following global ischemia in rat hearts. Tamiya Y; Yamamoto N; Uede T Immunopharmacology; 1995 Feb; 29(1):53-63. PubMed ID: 7768672 [TBL] [Abstract][Full Text] [Related]
17. ICAM-1 and LFA-1 on mouse epidermal Langerhans cells and spleen dendritic cells identify disparate requirements for activation of KLH-specific CD4+ Th1 and Th2 clones. Simon JC; Girolomoni G; Edelbaum D; Bergstresser PR; Cruz PD Exp Dermatol; 1993 Jun; 2(3):133-8. PubMed ID: 7909264 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury. Ghielli M; Verstrepen WA; De Greef KE; Helbert MH; Ysebaert DK; Nouwen EJ; De Broe ME Kidney Int; 2000 Sep; 58(3):1121-34. PubMed ID: 10972676 [TBL] [Abstract][Full Text] [Related]
19. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. Campanero MR; del Pozo MA; Arroyo AG; Sánchez-Mateos P; Hernández-Caselles T; Craig A; Pulido R; Sánchez-Madrid F J Cell Biol; 1993 Nov; 123(4):1007-16. PubMed ID: 7901223 [TBL] [Abstract][Full Text] [Related]
20. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes. de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]